HOME> product


Sales marketing
Bioactivity BC-05 is an orally active and potent inhibitor of CD13 and proteasome. BC-05 has an IC50 value of 0.13 μM for human CD13 and an IC50 value of 1.39 μM for the 20S proteasome. BC-05 can be used in multiple myeloma research[1].
Name BC-05
CAS 2260717-73-3
Formula C21H29BN2O9
Molar Mass 464.27
Transport Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Zhang J, et al. Discovery of a Novel Ubenimex Derivative as a First-in-Class Dual CD13/Proteasome Inhibitor for the Treatment of Cancer. Molecules. 2023 Aug 30;28(17):6343.

About Contact

© 2008-2024 PeptideDB SYSTEM All Rights Reserved